Target trial emulation for transparent and robust estimation of treatment effects for health technology assessment using real world data: opportunities and challenges

PharmacoEconomics

25 May 2022 - Evidence about the relative effects of new treatments is typically collected in randomised controlled trials. 

In many instances, evidence from randomised controlled trials falls short of the needs of health technology assessment.

Read PharmacoEconomics article

Michael Wonder

Posted by:

Michael Wonder